iShares US Healthcare Providers

JPMorgan cuts HCA Healthcare price target to $490

Wells Fargo Raises UnitedHealth Group's Price Target to $397

Judge grants Luigi Mangione's request to suppress evidence in UnitedHealth CEO murder case

UnitedHealth Group will hold its Annual General Meeting on June 2, 2026

North Dakota Investment Board Increases CVS Holdings as Q1 Earnings Beat Expectations

Berkshire Hathaway exited its entire position in UnitedHealth Group during the first quarter, causing the stock to slide 4% overnight.

CVS Health Joins CNCF as Platinum Member to Optimize Tech Architecture

UnitedHealthcare's D.C. Community Plan Earns NCQA Distinction for Long-Term Services and Supports

UnitedHealth's Optum Rx Introduces New Pharmacy Care Model for Transparency

UnitedHealth Group to Host UHC Medicare Sales Virtual Job Fair

DNB Asset Management Increases CVS Stake by 17.6%, Analysts Upgrade to Buy

Canada Post Corp Registered Pension Plan Increases Stake in UnitedHealth Group

Abacus Wealth Partners Invests $1.23M in Cigna Q4 as Earnings Beat Expectations

UnitedHealth Group Outlines Plan to Cut Medicare Advantage Members to Protect Profitability

UnitedHealth Group Expects to Complete at Least $2 Billion in Share Repurchases by End of Q2

Leuthold Group LLC acquired a new $9.29 million stake in UnitedHealth Group.

UnitedHealth's 2026 Health Trends Report projects an 8.5% increase in medical costs.

Qsemble Capital Management LP Makes New $3.42 Million Investment in UnitedHealth Group

Stephens Inc. AR Purchases 9,617 Shares of UnitedHealth Group

Regulatory framework for Pharmacy Benefit Managers (PBMs) may impact UnitedHealth's OptumRx division

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

AMPLITECH GROUP INC. USD0.001 S/R 20/11/26 SER B

Wellgistics Health

Huachen AI Parking Management Tech

GeoVax Labs

Sunshine Biopharma

AIM ImmunoTech

Virax Biolabs

NextNRG

GCT Semiconductor

HIMS

HIMY

HIMZ

Hims & Hers Health raises $350 million through convertible notes, aimed at supporting global expansion and accelerating AI-driven platform development.

Unusual Whales

Hims & Hers Health

Defiance Leveraged Long +Income HIMS ETF

Defiance Daily Target 2X Long HIMS ETF

SPDR S&P Health

VG Health

Health Care Select Sector SPDR

iShares Global Healthcare

Hims & Hers Health raises $350 million through convertible notes, aimed at supporting global expansion and accelerating AI-driven platform development.

UNHG

GSA Capital Partners LLP increased its stake in UnitedHealth Group (NYSE:UNH) by 203.2% in Q4, owning 6,673 shares valued at $2.2 million. Other institutional investors also raised their holdings. Analysts have upgraded their ratings, with Barclays setting a price target of $373.00. Despite Berkshire Hathaway's exit affecting sentiment, UnitedHealth's recent earnings showed positive results, maintaining a market cap of $354.57 billion.

Market Beat

Unitedhealth

Leverage Shares 2X Long UNH Daily ETF

Barclays

Jefferies Financial

KeyCorp

Berkshire Hathaway

Berkshire Hathaway B

Thomson Reuters

KEYCORP DEP SHS REP 1/40TH NON CUM PER PFD SER G

KEYCORP DEP SHS REPSTG 1/40TH INT PERP NON CUM H

KEYCORP DEP SHS REP 1/40TH PERP PFD SER F USD25

KEYCORP DEP SHS REP 1/40TH NON CUM PFD SER E

UnitedHealth Group Incorporated $UNH Holdings Boosted by GSA Capital Partners LLP

AMST

Amesite Inc. reported Q3 2026 revenue of $83.33K, a net loss of $678.06K, and diluted EPS of ($0.15), compared to $30.69K revenue and ($0.16) EPS in Q3 2025. Revenue growth for the nine months reached $285.7K, driven by a shift to healthcare markets and the launch of AI-driven NurseMagic™. The company focused on operational efficiency, reducing spending and shifting to monthly service contracts.

TradingView

Amesite

Amesite Inc. 3Q 2026: Revenue $83.33K, EPS ($0.15) — 10-Q Summary

BRK.A

BRK.B

Berkshire Hathaway has sold its entire stake in UnitedHealth, realizing a 45% profit as the stock rebounded from $271 to $394 in nine months. New CEO Greg Abel is reshaping the portfolio by reducing exposure to sectors with rising risks, such as healthcare and high-valuation tech. Berkshire initially invested in UnitedHealth during a crisis in 2025 marked by leadership issues and regulatory challenges.

- Berkshire Hathaway completely divested its UnitedHealth stake after a 45% increase in share price from $271 to $394 within nine months.  
- New CEO Greg Abel is restructuring the portfolio to minimize exposure to sectors with increasing risks, particularly healthcare and high-valuation technology.  
- UnitedHealth was acquired by Berkshire during a crisis in 2025 marked by leadership issues, regulatory investigations, and escalating costs.

Berkshire Hathaway exits UnitedHealth stake with 45% gain

Phoenix Financial Ltd. increased its holdings in UnitedHealth Group (NYSE:UNH) by 11.8% in Q4, owning 46,959 shares valued at $15.3 million. Other institutional investors also adjusted their positions. Analysts have raised price targets for UNH, with a consensus target of $378.88, reflecting positive sentiment around the stock's fundamentals and recent earnings performance.

Wells Fargo

JPMorgan Chase

WELLS FARGO & COMPANY DP SHS REP 1/1000TH INT NCUM PFD CL A DD

WELLS FARGO & COMPANY 7.5% PERP CONV PRF CLS 'A' SERIES 'L'

WELLS FARGO & COMPANY DEP SHS REP 1/1000 INT PER PFD SER Y A

WELLS FARGO & COMPANY DP SHS REP 1/1000TH INT NCUM PFD CL A CC

WELLS FARGO & COMPANY 4.75% DEP SHS 1/1000 NCUM PFD CL A SR Z

WELLS FARGO & COMPANY DEP SHS REP 1/1000TH INT PFD SR AA (CLA)

JPMORGAN CHASE & CO. 4.20% DEP SHS REPSTG 1/400TH PFD SER MM

JPMORGAN CHASE & CO. 6%NON CUM DEP SHS REP 1/400TH PFD SER EE

JPMORGAN CHASE & CO. DEP REP 1/400TH (5.75% NON CUM PFD DD)

JPMORGAN CHASE & CO. 4.625% DEP SH RE 1/400TH INT NO CU PF LL

JPMorgan Chase & Co.

JPMORGAN CHASE & CO. 4.55% DEP SHS REPSTG 1/400TH PFD SER JJ

JPMORGAN CHASE & CO. 4.75 DEP SHS REP 1/400 NCUM PFD SR GG

Phoenix Financial Ltd. Grows Position in UnitedHealth Group Incorporated $UNH

Caris Life Sciences Publishes Study on the Caris Lookback Program Demonstrating the Ongoing Clinical Value of Comprehensive Testing with Caris MI Cancer Seek | CAI Stock News

StockTitan

Caris Life Sciences

SPDR S&P Biotech

First Trust NYSE Arca Biotech Index Fd

Proshares Ultra Nasdaq Biotech

Ark Genomic Revolution ETF

iShares US Medical Devices

ALPS Medical Breakthrough

VanEck Biotech ETF

Invesco Biotechnology & Genome ETF

iShares Biotechnology ETF

iShares Genomics Immunology and Healthcare ETF

Direxion S&P Biotech Bull 3X

Caris Life Sciences Publishes Study on the Caris Lookback Program Demonstrating the Ongoing Clinical Value of Comprehensive Testing with Caris MI Cancer Seek | CAI Stock News

LGMKD

LGMK

LogicMark, Inc. reported a 24% year-over-year revenue increase to $3.2 million for Q1 2026, with gross margins rising to 69.6%. Operating expenses decreased by 7%, narrowing the operating loss to $1.5 million. The company is shifting towards a connected-care platform, focusing on healthcare and B2B distribution. Despite ongoing losses, Spark's AI Analyst rates LGMK as Neutral, citing improving revenue and margins but weak financial performance.

Tip Ranks

LOGICMARK INC

LogicMark

SPDR S&P Health Equip

LogicMark posts strong Q1 growth, margins and outlook

OPCH

Zacks Research downgraded Option Care Health (NASDAQ:OPCH) from a "hold" to a "strong sell" rating. Other analysts have varied opinions, with Jefferies maintaining a "buy" rating and a $37 target price, while TD Cowen lowered their target to $23. The stock opened at $19.59, down 1.2%, with a market cap of $3.08 billion. Recent insider purchases include CEO John Rademacher acquiring 12,500 shares. Analysts expect Option Care Health to post 1.64 EPS for the current year, with a consensus rating of "Moderate Buy" and an average target price of $31.25.

Option Care Health

Morgan Stanley

Citizens Financial

MORGAN STANLEY DEP SHS EA REP 1/1000 SHS NON CUM PFD O

MORGAN STANLEY DEP SHS REPSTG 1/1000TH PFD SER Q

MORGAN STANLEY DEP SHS REPS 1/1000 7.125% PFD E

MORGAN STANLEY NON-CUM DEP SH REP 1/1000 PFD SER I

MORGAN STANLEY 4.875 DEP SHS REP 1/1000 NCUM PFD SR L

MORGAN STANLEY 6.5%DEP SHS REPSTG 1/1000 NON CUM SER P

MORGAN STANLEY DEP SHS REPS 1/1000 PFD SER 'A'

MORGAN STANLEY DEP SHS REPR 1/1000TH INT PFD SER 'F' FX

MORGAN STANLEY DEP SHS REP 1/1000 NON-CUM PFD STK SER K

CITIZENS FINANCIAL GROUP INC DEP SHS REPSTG 1/40TH PERP PFD SR I

CITIZENS FINANCIAL GROUP INC 5% DEP SHS EA REP 1/40TH NON CUM SER E

CITIZENS FINANCIAL GROUP INC DEP SHS REPSTG 1/40TH PERP PFD SER H

Option Care Health (NASDAQ:OPCH) Stock Rating Lowered by Zacks Research

Berkshire Hathaway sold its entire stake in UnitedHealth in Q1 2026, leading to a decline in the insurer's stock. CEO Greg Abel's strategy reflects a shift towards quicker trades, contrasting with Warren Buffett's long-term approach. Despite the sell-off, UnitedHealth is exceeding earnings forecasts and focusing on AI investments and cost controls to enhance profitability.

- Berkshire Hathaway divested its entire UnitedHealth position in Q1 2026, leading to a decline in the insurer's stock.  
- CEO Greg Abel is adopting a strategy of quicker trades and capital redeployment, contrasting with Warren Buffett's long-term investment approach.  
- Despite the sell-off, UnitedHealth is exceeding earnings forecasts and focusing on AI investments and cost controls to enhance profitability.

Berkshire's UnitedHealth exit sends shares lower despite turnaround

ALHC

Alignment Healthcare (NASDAQ:ALHC) remains optimistic about its Q2 outlook, citing stable medical costs and growth opportunities outside California. Executives reported improvements in medical benefit ratios and adjusted EBITDA, with 80% year-over-year growth. They emphasized strong data visibility and a care-centric model, which positions them favorably against competitors. Expansion into new markets is expected to enhance margins, despite higher medical loss ratios initially. The company is also monitoring potential changes in Medicare Advantage risk models and their implications for future growth.

Alignment Healthcare

Alignment Healthcare Backs Q2 Outlook as Stable Costs, New Markets Lift Margin Hopes

iShares US Healthcare Providers(IHF.US)

Hims & Hers Health raises $350 million through convertible notes, aimed at supporting global expansion and accelerating AI-driven platform development.

UnitedHealth Group Incorporated $UNH Holdings Boosted by GSA Capital Partners LLP

Amesite Inc. 3Q 2026: Revenue $83.33K, EPS ($0.15) — 10-Q Summary

Berkshire Hathaway exits UnitedHealth stake with 45% gain

Phoenix Financial Ltd. Grows Position in UnitedHealth Group Incorporated $UNH